Transient receptor potential vanilloid 4 channel regulates vascular endothelial permeability during colonic inflammation in dextran sulphate sodium‐induced murine colitis
Open Access
- 20 October 2017
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 175 (1) , 84-99
Abstract
Background and Purpose: The transient receptor potential vanilloid 4 (TRPV4) channel is a non‐selective cation channel involved in physical sensing in various tissue types. The present study aimed to elucidate the function and expression of TRPV4 channels in colonic vascular endothelial cells during dextran sulphate sodium (DSS)‐induced colitis.Experimental Approach: The role of TRPV4 channels in the progression of colonic inflammation was examined in a murine DSS‐induced colitis model using immunohistochemical analysis, Western blotting and Evans blue dye extrusion assay.Key Results: DSS‐induced colitis was significantly attenuated in TRPV4‐deficient (TRPV4 KO) as compared to wild‐type mice. Repeated intrarectal administration of GSK1016790A, a TRPV4 agonist, exacerbated the severity of DSS‐induced colitis. Bone marrow transfer experiments demonstrated the important role of TRPV4 in non‐haematopoietic cells for DSS‐induced colitis. DSS treatment up‐regulated TRPV4 expression in the vascular endothelia of colonic mucosa and submucosa. DSS treatment increased vascular permeability, which was abolished in TRPV4 KO mice. This DSS‐induced increase in vascular permeability was further enhanced by i.v. administration of GSK1016790A, and this effect was abolished by the TRPV4 antagonist RN1734. TRPV4 was co‐localized with vascular endothelial (VE)‐cadherin, and VE‐cadherin expression was decreased by repeated i.v. administration of GSK1016790A during colitis. Furthermore, GSK106790A decreased VE‐cadherin expression in mouse aortic endothelial cells exposed to TNF‐α.Conclusion and Implications: These findings indicate that an up‐regulation of TRPV4 channels in vascular endothelial cells contributes to the progression of colonic inflammation by increasing vascular permeability. Thus, TRPV4 is an attractive target for the treatment of inflammatory bowel diseases.Keywords
Funding Information
- Takeda Science Foundation
This publication has 58 references indexed in Scilit:
- Tumour necrosis factor‐α‐mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin‐6Journal of Neurochemistry, 2015
- Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmissionJournal of Molecular Medicine, 2015
- Role of TRP channels in the cardiovascular systemAmerican Journal of Physiology-Heart and Circulatory Physiology, 2015
- TRPV4 channel activation leads to endothelium-dependent relaxation mediated by nitric oxide and endothelium-derived hyperpolarizing factor in rat pulmonary arteryPharmacological Research, 2013
- Role of Caspases in Cytokine-Induced Barrier Breakdown in Human Brain Endothelial CellsThe Journal of Immunology, 2012
- TRP channels: Emerging targets for respiratory diseasePharmacology & Therapeutics, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Modulation of the Ca 2 Permeable Cation Channel TRPV4 by Cytochrome P450 Epoxygenases in Vascular EndotheliumCirculation Research, 2005
- Protective Effect of Lafutidine, a Novel Histamine H2-Receptor Antagonist, on Dextran Sulfate Sodium-Induced Colonic Inflammation Through Capsaicin-Sensitive Afferent Neurons in RatsDigestive Diseases and Sciences, 2004
- Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in ratsGut, 2003